![](/img/cover-not-exists.png)
121PAXL expression predicts poor prognosis and lack of efficacy of anti-angiogenic and anti-epidermal growth factor receptor (EGFR) agents in patients (pts) with RAS wild type (WT) metastatic colorectal cancer (mCRC)
Cardone, C, Blauensteiner, B, Moreno-Viedma, V, Vitiello, P P, Martini, G, Ciardiello, D, Simeon, V, Rachiglio, A M, Rizzi, D, Maiello, E, Latiano, T, Cremolini, C, Argiles Martinez, G, Elez, E, FalcoVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz239.032
Date:
October, 2019
File:
PDF, 111 KB
2019